Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mantecorp is a leading Brazilian pharmaceutical company that operates as a core subsidiary of Hypera Pharma, the largest pharmaceutical group in Brazil. Founded in 1948, the company established itself as a powerhouse in dermatology, respiratory medicine, and primary care. It is widely recognized for its Mantecorp Skincare division, which holds a dominant position in the Brazilian dermo-cosmetics market with flagship brands such as Episol and Epidrat. In 2011, Mantecorp was acquired by Hypermarcas (now Hypera Pharma) for approximately R$ 2.5 billion, a move that significantly expanded Hypera's presence in the prescription drug market. The company operates state-of-the-art manufacturing facilities in Anápolis, Brazil, and continues to be a key driver of innovation in the branded generics and over-the-counter segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mantecorp Industria Quimica e Farmaceutica.